Rchr
J-GLOBAL ID：202001016418293756
Update date: Sep. 15, 2024
Hamamoto Ryuji
ハマモト リュウジ | Hamamoto Ryuji
Affiliation and department：
Other affiliations (2)：
-
RIKEN
Center for Advanced Intelligence Project (AIP)
-
内閣府BRIDGE事業
PD(プログラムディレクター)
Homepage URL (1)：
https://www.ncc.go.jp/jp/ri/division/molecular_modification_and_cancer_biology/index.html
Research field (1)：
Tumor biology
Research keywords (2)：
Medical AI
, Machine Learning
Papers (180)：
-
Mayumi Kobayashi Kato, Erisa Fujii, Maiko Yamaguchi, Daiki Higuchi, Yuka Asami, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Koji Matumoto, Tomoyasu Kato, et al. Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma. Gynecologic Oncology. 2024. 190. 139-145
-
Satoshi Takahashi, Yusuke Sakaguchi, Nobuji Kouno, Ken Takasawa, Kenichi Ishizu, Yu Akagi, Rina Aoyama, Naoki Teraya, Amina Bolatkan, Norio Shinkai, et al. Comparison of Vision Transformers and Convolutional Neural Networks in Medical Image Analysis: A Systematic Review. Journal of medical systems. 2024. 48. 1. 84-84
-
Ken Asada, Syuzo Kaneko, Ken Takasawa, Kouya Shiraishi, Norio Shinkai, Yoko Shimada, Satoshi Takahashi, Hidenori Machino, Kazuma Kobayashi, Amina Bolatkan, et al. Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets. Molecular cancer. 2024. 23. 1. 182-182
-
Kazuma Kobayashi, Yasuyuki Takamizawa, Mototaka Miyake, Sono Ito, Lin Gu, Tatsuya Nakatsuka, Yu Akagi, Tatsuya Harada, Yukihide Kanemitsu, Ryuji Hamamoto. Can physician judgment enhance model trustworthiness? A case study on predicting pathological lymph nodes in rectal cancer. Artificial Intelligence in Medicine. 2024. 102929-102929
-
Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, et al. Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Molecular Cancer. 2024. 23. 1
ｍore...
Work history (9)：
- 2023/06 - 現在 内閣府BRIDGE事業 PD(プログラムディレクター)*2024年6月まではPM(研究総括)
- 2017/04 - 現在 RIKEN
- 2016/04 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences
- 2016/01 - 現在 Division of Medical AI Research and Development, National Cancer Center Research Institute
- 2012/11 - 2015/12 The University of Chicago Department of Medicine Associate Professor
- 2007/04 - 2012/10 The University of Tokyo The Institute of Medical Science Assistant Professor
- 2006/01 - 2007/12 University of Cambridge Department of Oncology Honorary Visiting Fellow
- 2001/11 - 2007/03 The University of Tokyo The Institute of Medical Science Assistant Professor
- 2000 - 2001/10 東京大学 医科学研究所
Show all
Association Membership(s) (5)：
日本メディカルAI学会
, アメリカ癌学会
, 日本がん分子標的治療学会
, 日本癌学会
, 日本オミックス医学会
